These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11031423)

  • 1. [Discrimination between the effects of hypolipidemic and antiatherogenic drugs: probucol pharmacokinetics (review of the literature)].
    Titov VN; Zaĭtseva TM
    Klin Lab Diagn; 2000 Aug; (8):3-9. PubMed ID: 11031423
    [No Abstract]   [Full Text] [Related]  

  • 2. Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.
    Lauridsen ST; Mortensen A
    Atherosclerosis; 1999 Jan; 142(1):169-78. PubMed ID: 9920518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical research on the hypolipidemic action of a probucol preparation].
    Naumova R; Kerekovska M; Goranov I; Balabanski L
    Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty.
    Watanabe K; Sekiya M; Ikeda S; Miyagawa M; Hashida K
    Am Heart J; 1996 Jul; 132(1 Pt 1):23-9. PubMed ID: 8701872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
    Carew TE; Schwenke DC; Steinberg D
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7725-9. PubMed ID: 3478721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacology of probucol. I].
    Donatelli L
    Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of probucol on lipoprotein protein kinetics.
    Nestel PJ
    Artery; 1982; 10(2):95-8. PubMed ID: 7092582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of anti-atherogenic action of probucol].
    Ohya T; Egusa G
    Nihon Rinsho; 1999 Dec; 57(12):2831-6. PubMed ID: 10638221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of LDL-apheresis on the pharmacokinetics of the lipophilic antilipidemic agent probucol.
    Komura T; Takahara K; Sugano M; Fujinishi A; Tasaki H; Nakashima Y; Kuroiwa A
    Eur J Drug Metab Pharmacokinet; 1997; 22(3):201-6. PubMed ID: 9358199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoproteins and atherosclerosis.
    Kita T; Ishii K; Yokode M; Kume N; Nagano Y; Otani H; Arai H; Ueda Y; Kawai C
    Jpn Circ J; 1990 Sep; 54(9):1226-32. PubMed ID: 2176246
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dyslipidemia characteristics in arterial hypertension].
    Neverov IV; Baĭmatova DD
    Sov Med; 1984; (6):46-9. PubMed ID: 6379903
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of left ventricular dysfunction associated with sustained exposure to hyperlipidemia following lung transplantation.
    Kesten S; Mayne L; Scavuzzo M; Maurer J
    Chest; 1997 Oct; 112(4):931-6. PubMed ID: 9377955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypolipidemic activity of trimethylglycine].
    Kliueva NN; Kalashnikova NM; Okunevich IV; Sapronov NS
    Eksp Klin Farmakol; 2012; 75(1):16-8. PubMed ID: 22442957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
    Oshima R; Ikeda T; Watanabe K; Itakura H; Sugiyama N
    Atherosclerosis; 1998 Mar; 137(1):13-22. PubMed ID: 9568732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Ginkgo biloba extract on the proliferation of vascular smooth muscle cells in vitro and on intimal thickening and interleukin-1beta expression after balloon injury in cholesterol-fed rabbits in vivo.
    Lin SJ; Yang TH; Chen YH; Chen JW; Kwok CF; Shiao MS; Chen YL
    J Cell Biochem; 2002; 85(3):572-82. PubMed ID: 11967997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management of hyperlipidemia and the role of probucol.
    Davignon J
    Am J Cardiol; 1986 Jun; 57(16):22H-28H. PubMed ID: 3460320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient care after percutaneous coronary artery interventions.
    Rashdan I
    Ann Intern Med; 1998 Apr; 128(7):598; author reply 599-600. PubMed ID: 9518409
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of atherosclerotic progression in Watanabe rabbits by probucol.
    Kita T; Nagano Y; Yokode M; Ishii K; Kume N; Narumiya S; Kawai C
    Am J Cardiol; 1988 Jul; 62(3):13B-19B. PubMed ID: 3394648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basic principles of drug therapy of hyperlipoproteinemia].
    Romics L
    Orv Hetil; 1988 Nov; 129(45):2391-9. PubMed ID: 3054710
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined treatment of probucol with diltiazem regresses atherosclerosis induced by 196 cholesterol diet in rabbit aorta.
    Kouzuma R; Tasaki H; Komura T; Nakashima Y; Kuroiwa A; Tanimoto A; Koide O
    Artery; 1995; 21(6):337-51. PubMed ID: 8833232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.